Benefits of Combining SGLT2 Inhibitors with GLP-1 Receptor Agonists on Cardiovascular Outcomes The summarized information indicates that the evidence from primary prevention studies is less robust than that derived from secondary prevention studies
When I had a question about timing and side effects, I got a clear answer and felt like someone was actually paying attention
PMID: 18065594
Pyroxidine is known to reduce the effectiveness of altretamine, especially when combined with cisplatin
At Advanced Medical Care in Queens and Brooklyn, our board-certified specialists see this connection often: poor sleep fuels oxidative stress, and oxidative stress, in turn, wrecks sleep
Randomized, double-blind, placebo-controlled, phase III cross-over study evaluating the oral neurokinin-1 antagonist aprepitant in combination with a 5HT3 receptor antagonist and dexamethasone in patients with germ cell tumors receiving 5-day cisplatin combination chemotherapy regimens: a hoosier oncology group study